Standard Family Office’s Charles River Laboratories CRL Stock Holding History

Standard Family Office’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-322	Closed	-$63K	–	98
2022 Q3	$63K	Buy	+322	New	+$69.5K	0.03%	106
2022 Q2	–	Sell	-367	Closed	-$104K	–	222
2022 Q1	$104K	Buy	+367	New	+$113K	0.03%	36
2021 Q3	–	Sell	-576	Closed	-$213K	–	170
2021 Q2	$213K	Hold	576	–	–	0.04%	147
2021 Q1	$167K	Hold	576	–	–	0.04%	143
2020 Q4	$144K	Buy	+576	New	+$137K	0.03%	155

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Standard Family Office's CRL Position: Q4 2022 in Review

Standard Family Office sold out of Charles River Laboratories (CRL) in Q4 2022, closing a stake of 322 shares — an estimated $63K sold.

Standard Family Office first reported a position in CRL in Q4 2020 and held it in 5 quarters. The position peaked at $213K in Q2 2021. 627 funds tracked by Wall St. Rank hold CRL as of Q4 2022.

Standard Family Office reported no remaining Charles River Laboratories position as of Q4 2022 after selling out during the quarter.
Standard Family Office sold 322 Charles River Laboratories shares in Q4 2022, an estimated $63K.
Standard Family Office first reported a position in Charles River Laboratories in Q4 2020 and held it in 5 quarters.
Standard Family Office's Charles River Laboratories position peaked at $213K in Q2 2021.
627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2022.

Based on Standard Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.